scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "Drug and Narcotic Control organization & administration"

1 - 10 of 32,381 results for
 "Drug and Narcotic Control organization & administration"
Results per page:

Fulfilling the Mandate of the US Food and Drug Administration's Accelerated Approval Pathway: The Need for Reforms.

Publication Type: Academic Journal

Source(s): JAMA internal medicine [JAMA Intern Med] 2021 Oct 01; Vol. 181 (10), pp. 1275-1276.

African Medicines Agency to be established.

Publication Type: Academic Journal

Source(s): Lancet (London, England) [Lancet] 2021 Oct 23; Vol. 398 (10310), pp. 1475.

Authors:

Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?

Publication Type: Academic Journal

Source(s): BMJ (Clinical research ed.) [BMJ] 2020 Oct 08; Vol. 371, pp. m3841. Date of Electronic Publication: 2020 Oct 08.

Abstract: Competing Interests: Competing interests: We have read and understood BMJ policy on declaration of interests and have no interests to declare. Provenance and peer review: Not commissioned; externally peer reviewed.

Extent of a valsartan drug shortage and its effect on antihypertensive drug use in the Canadian population: a national cross-sectional study.

Publication Type: Academic Journal

Source(s): CMAJ open [CMAJ Open] 2021 Dec 07; Vol. 9 (4), pp. E1128-E1133. Date of Electronic Publication: 2021 Dec 07 (Print Publication: 2021).

Abstract: Background: Drug shortages represent a growing global problem, with potentially serious consequences to patients and the health care system. Our study investigates the impacts of a major recall and shortage of valsartan, an angiotensin receptor blocker...

Increasing Use of Compassionate Use/Managed Access Channels to Obtain Medicines for Use in COVID-19.

Publication Type: Academic Journal

Source(s): Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Jul; Vol. 110 (1), pp. 26-28. Date of Electronic Publication: 2020 Dec 28.

Dismantling War on Drugs Policies in COVID-19's Aftermath.

Publication Type: Report

Source(s): American journal of public health [Am J Public Health] 2022 Feb; Vol. 112 (S1), pp. S24-S27.

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment.

Publication Type: Academic Journal

Source(s): Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2021 Jan; Vol. 49 (1), pp. 94-110. Date of Electronic Publication: 2020 Nov 02.

Abstract: Translational and ADME Sciences Leadership Group Induction Working Group (IWG) presents an analysis on the time course for cytochrome P450 induction in primary human hepatocytes. Induction of CYP1A2, CYP2B6, and CYP3A4 was evaluated by seven IWG labora...

Is BCG a Hazardous Drug? Ask NIOSH, OSHA, and the USP.

Publication Type: Editorial & Opinion

Source(s): The Canadian journal of urology [Can J Urol] 2019 Apr; Vol. 26 (2), pp. 9687-9689.

Authors:

The long tail of a demon drug: The 'bath salts' risk environment.

Publication Type: Academic Journal

Source(s): The International journal on drug policy [Int J Drug Policy] 2018 Jan; Vol. 51, pp. 111-116. Date of Electronic Publication: 2017 Dec 15.

Abstract: Using the case of synthetic cathinones (commonly referred to as 'bath salts' in the US context), this paper analyses structural factors surrounding novel psychoactive substances (NPS) as contributing to the unique risk environment surrounding their use...

The High Cost of Insulin in the United States: An Urgent Call to Action.

Publication Type: Academic Journal

Source(s): Mayo Clinic proceedings [Mayo Clin Proc] 2020 Jan; Vol. 95 (1), pp. 22-28.

Authors:
sponsored